RxDoctor Payments DataLook up a doctor →

Eric Camyre, DO

Family Medicine · Vernon, CTNPI 1831326461

Payments from drug & device makers

$25,843in general payments, 2019–2025

Across 1,379 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Novo Nordisk$3K
  • AstraZeneca$2K
  • GSK$2K
  • Boehringer Ingelheim$1K
  • Lilly USA, LLC$1K
  • plus $13K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)210$3,678
Novo Nordisk130$2,670
AstraZeneca116$2,175
GSK116$1,977
Boehringer Ingelheim74$1,494
Lilly USA, LLC70$1,262
Pfizer59$1,177
Amgen57$1,018
Merck47$822
Sanofi-aventis U.S. LLC47$801
Abbott34$632
Johnson & Johnson40$621
Novartis36$620
Bayer21$617
Astellas Pharma US Inc27$590
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC34$533
Amarin Pharma, Inc.24$488
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)19$432
Phathom Pharmaceuticals, Inc.13$384
Lundbeck LLC25$380
Exact Sciences12$298
E.r. Squibb & Sons, L.L.C.11$286
Sumitomo Pharma America, Inc.11$257
Scilex Pharmaceuticals Inc.14$254
Ardelyx, Inc.7$167
Dexcom, Inc.12$156
Otsuka America Pharmaceutical, Inc.6$142
Corcept Therapeutics6$137
Avanir Pharmaceuticals, Inc.10$129
Circassia Inc.9$127
Idorsia Pharmaceuticals US Inc7$121
Sunovion Pharmaceuticals Inc.6$119
Azurity Pharmaceuticals, Inc.6$111
Takeda Pharmaceuticals U.S.A., Inc.5$107
Kowa Pharmaceuticals America, Inc.7$90
Eisai Inc.4$87
Actelion Pharmaceuticals US, Inc.3$79
Biogen3$54
Vifor Pharma, Inc.3$52
Lifescan, Inc.3$50
Biohaven Pharmaceuticals, Inc.2$45
Bristol Myers Squibb2$44
Shield Therapeutics Inc2$42
Antares Pharma, Inc.2$39
MDD US Operations, LLC2$35
Vanda Pharmaceuticals Inc.1$33
Covis Pharma GmbH2$33
Cequr Corporation1$31
Currax Pharmaceuticals LLC2$30
Ironwood Pharmaceuticals, Inc2$27
Arbor Pharmaceuticals, Inc.2$26
QOL Medical, LLC1$24
Inspire Medical Systems, Inc.1$24
Agios Pharmaceuticals, Inc.1$23
Paratek Pharmaceuticals, Inc.1$19
Axsome Therapeutics, Inc.1$19
Acerus Pharmaceuticals Corporation1$19
Shire North American Group Inc1$18
Nestle Healthcare Nutrition Inc.1$18
Teva Pharmaceuticals USA, Inc.1$18

How this compares

$25,843 in reported general payments places this provider in the 95th percentile of 588 family medicine providers in Connecticut.

See all family medicine providers in Connecticut →

Medicare billing

Part B allowed, 2024
$109,626
Medicare patients
302
Services billed
1,326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Vernon

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →